相关实验视频

Updated: Jun 28, 2025

In Vivo Imaging to Measure Spontaneous Lung Metastasis of Orthotopically-injected Breast Tumor Cells

In Vivo Imaging to Measure Spontaneous Lung Metastasis of Orthotopically-injected Breast Tumor Cells

Published on: June 23, 2022

导航乳腺癌的寡头转移和寡头进展:当前景观和未来方向

Stephanie M Yoon¹, Jose G Bazan²

¹Department of Radiation Oncology, City of Hope Comprehensive Cancer Center, 1500 E. Duarte Road, Duarte, CA, 91010, USA.

Current oncology reports

|April 23, 2024

概括

像手术和SBRT这样的局部废除疗法对小卵性 (OM) 和小卵性 (OP) 乳腺癌有前途. 然而,由于潜在的毒性,当前的随机数据不支持它们的常规使用.

科学领域:

在瘤学瘤学.
乳腺癌研究研究乳腺癌研究

背景情况:

转移性乳腺癌 (MBC) 对治愈治疗提出了挑战.
在MBC中,寡聚性 (OM) 和寡进性 (OP) 疾病代表了特定的临床情景.

研究的目的:

审查关于OM和OP乳腺癌局部废除疗法的文献.
评估在选择的MBC患者中治疗方法的潜力.

主要方法:

对OM/OP乳腺癌手术和立体体辐射疗法 (SBRT) 的研究进行文献综述.
对回顾性和非随机试验数据的分析.

主要成果:

几项研究表明,对OM/OP乳腺癌的手术和SBRT有有利的结果.
有矛盾的结果,一些试验显示这些局部疗法没有益处.

结论:

目前的随机数据不支持对OM/OP乳腺癌的手术或SBRT的常规使用.
必须考虑与处理相关的毒性.
未来的研究应该专注于改进患者选择,可能使用先进的成像,以及特定的亚型,如激素受体阳性或HER2阳性疾病.

关键词:

乳腺癌乳腺癌乳腺癌这是一种寡头性转移.寡头渐进型寡头渐进型立体性身体放射治疗立体性身体放射治疗

更多相关视频

A Portal Vein Injection Model to Study Liver Metastasis of Breast Cancer

A Portal Vein Injection Model to Study Liver Metastasis of Breast Cancer

Published on: December 26, 2016

Studying Triple Negative Breast Cancer Using Orthotopic Breast Cancer Model

Studying Triple Negative Breast Cancer Using Orthotopic Breast Cancer Model

Published on: March 20, 2020

相关概念视频

Tumor Progression

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...